Adial Pharmaceuticals, Inc. (ADIL)

Adial Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.83	4	6.06	4.4	6.78
Cash & Cash Equivalents	2.83	4	6.06	4.4	6.78
Cash Growth	-29.35%	-33.99%	37.74%	-35.06%	75.16%
Other Current Assets	0.37	0.78	0.4	0.73	0.9
Total Current Assets	3.2	4.78	6.46	5.14	7.67
Property, Plant & Equipment	0	0	0.3	0	0
Long-Term Investments	1.53	0	0	0	0
Goodwill and Intangibles	0	0	0.25	0.01	0.01
Other Long-Term Assets	0	0.95	0.46	0.35	0
Total Long-Term Assets	1.54	0.95	1.01	0.36	0.01
Total Assets	4.74	5.73	7.47	5.49	7.68
Accounts Payable	0.13	0.28	0.29	0.65	0.19
Current Debt	0	0	0.05	0	0
Other Current Liabilities	0.53	1.51	2.39	0.86	0.35
Total Current Liabilities	0.65	1.79	2.72	1.51	0.54
Long-Term Debt	0	0	0.21	0	0
Other Long-Term Liabilities	0	0.67	1.04	0	0
Total Long-Term Liabilities	0	0.67	1.24	0	0
Total Liabilities	0.65	2.46	3.97	1.51	0.54
Total Debt	0	0	0.26	0	0
Retained Earnings	-68.8	-63.67	-50.94	-31.52	-20.63
Shareholders' Equity	4.08	3.28	3.51	3.99	7.14
Net Cash / Debt	2.83	4	5.81	4.4	6.78
Net Cash / Debt Growth	-29.35%	-31.07%	31.90%	-35.06%	75.16%
Net Cash Per Share	1.98	4.00	7.81	8.83	17.20
Working Capital	2.55	2.99	3.74	3.63	7.13
Book Value Per Share	2.87	3.27	4.72	8.00	18.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).